We wish to thank Ute Handte-Daub, Ansgar Brandhorst, and Petra Bächer for their excellent technical assistance. We are particularly grateful to the study participants and interviewers who assisted in the data collection. We also gratefully appreciate the cooperation of the following clinics and institutions: Chirurgische Universitätsklinik Heidelberg, Klinik am Gesundbrunnen Heilbronn, St. Vincentiuskrankenhaus Speyer, St. Josefskrankenhaus Heidelberg, Chirurgische Universitätsklinik Mannheim, Diakonissenkrankenhaus Speyer, Krankenhaus Salem Heidelberg, Kreiskrankenhaus Schwetzingen, St. Marienkrankenhaus Ludwigshafen, Klinikum Ludwigshafen, Stadtklinik Frankenthal, Diakoniekrankenhaus Mannheim, Kreiskrankenhaus Sinsheim, Klinikum am Plattenwald Bad Friedrichshall, Kreiskrankenhaus Weinheim, Kreiskrankenhaus Eberbach, Kreiskrankenhaus Buchen, Kreiskrankenhaus Mosbach, Enddarmzentrum Mannheim, Kreiskrankenhaus Brackenheim, and Cancer Registry of Rhineland-Palatinate, Mainz.
Bray F, Ferlay J, Soerjomataram I, . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.
Holleczek B, Rossi S, Domenic A, . On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 – results from the EUROCARE-5 study. Eur J Cancer 2015;51:2158–2168.
Arnold M, Sierra MS, Laversanne M, . Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017;66:683–691.
Yancik R, Ershler W, Satariano W, . Report of the national institute on aging task force on comorbidity. J Gerontol A Biol Sci Med Sci 2007;62:275–280.
Hines RB, Chatla C, Bumpers HL, . Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer. J Clin Oncol 2009;27:4339–4345.
Iversen LH, Nørgaard M, Jacobsen J, . The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006—a population-based cohort study. Dis Colon Rectum 2009;52:71–78.
Kristjansson SR, Jordhoy MS, Nesbakken A, . Which elements of a comprehensive geriatric assessment (CGA) predict post-operative complications and early mortality after colorectal cancer surgery? J Geriatr Oncol 2010;1:57–65.
Ostenfeld EB, Nørgaard M, Thomsen RW, . Comorbidity and survival of Danish patients with colon and rectal cancer from 2000-2011: a population-based cohort study. Clin Epidemiol 2013;5(Suppl 1):65–74.
Marventano S, Grosso G, Mistretta A, . Evaluation of four comorbidity indices and Charlson comorbidity index adjustment for colorectal cancer patients. Int J Colorectal Dis 2014;29:1159–1169.
Wu CC, Hsu TW, Chang CM, . Age-adjusted Charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation. Medicine (Baltimore) 2015;94:e431.
Booth CM, Nanji S, Wei X, . Use and effectiveness of adjuvant chemotherapy for stage III colon cancer: a population-based study. J Natl Compr Canc Netw 2016;14:47–56.
Nayak P, Luo R, Elting L, . Impact of rheumatoid arthritis on the mortality of elderly patients who develop cancer: a population-based study. Arthritis Care Res (Hoboken) 2017;69:75–83.
Yamano T, Yamauchi S, Kimura K, . Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: a retrospective multicentre study. Eur J Cancer 2017;81:90–101.
Brungs D, Aghmesheh M, de Souza P, . Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients. BMC Cancer 2017;17:251.
Parés-Badell O, Banqué M, Macià F, . Impact of comorbidity on survival by tumour location: breast, colorectal and lung cancer (2000-2014). Cancer Epidemiol 2017;49:66–74.
Brenner H, Chang-Claude J, Jansen L, . Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology 2014;146:709–717.
Hoffmeister M, Jansen L, Rudolph A, . Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment. J Natl Cancer Inst 2015;107:djv045.
Charlson ME, Pompei P, Ales KL, . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–619.
Brenner H, Gefeller O, Greenland S. Risk and rate advancement periods as measures of exposure impact on the occurrence of chronic diseases. Epidemiology 1993;4:229–236.
Ordóñez-Mena JM, Schöttker B, Mons U, . Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium. BMC Med 2016;14:62.
Keil U, Liese AD, Hense HW, . Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring Trends and Determinants in Cardiovascular Diseases. Eur Heart J 1998;19:1197–1207.
- Search Google Scholar
- Export Citation
)| false . , Keil U , Liese AD , Hense HW Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring Trends and Determinants in Cardiovascular Diseases. 1998; 19: 1197– 1207.
Ford ES, Zhao G, Tsai J, . Low-risk lifestyle behaviors and all-cause mortality: findings from the National Health and Nutrition Examination Survey III Mortality Study. Am J Public Health 2011;101:1922–1929.
Leenders M, Sluijs I, Ros MM, . Fruit and vegetable consumption and mortality: European prospective investigation into cancer and nutrition. Am J Epidemiol 2013;178:590–602.
Raina P, Gilsing A, Freisling H, . The combined effect of cancer and cardio-metabolic conditions on the mortality burden in older adults. J Gerontol A Biol Sci Med Sci 2019;4:366–372.
Hahn EE, Gould MK, Munoz-Plaza CE, . Understanding comorbidity profiles and their effect on treatment and survival in patients with colorectal cancer. J Natl Compr Canc Netw 2018;16:23–34.
Sarfati D, Hill S, Blakely T, . The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC Cancer 2009;9:116.
Elliot AH, Martling A, Glimelius B, . Impact of pre-treatment patient-related selection parameters on outcome in rectal cancer. Eur J Surg Oncol 2016;42:1667–1673.
Boakye D, Rillmann B, Walter V, . Impact of comorbidity and frailty on prognosis in colorectal cancer patients: a systematic review and meta-analysis. Cancer Treat Rev 2018;64:30–39.
Cuthbert CA, Hemmelgarn BR, Xu Y, . The effect of comorbidities on outcomes in colorectal cancer survivors: a population-based cohort study. J Cancer Surviv 2018;12:733–743.
Erichsen R, Horváth-Puhó E, Iversen LH, . Does comorbidity interact with colorectal cancer to increase mortality? A nationwide population-based cohort study. Br J Cancer 2013;109:2005–2013.
Petrelli F, Tomasello G, Borgonovo K, . Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA Oncol 2017;3:211–219.
Jørgensen TL, Hallas J, Friis S, . Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer 2012;106:1353–1360.
Schmiegel W, Pox C, Reinacher-Schick A, . S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol 2010;48:65–136.
Zhang ZY, Luo QF, Yin XW, . Nomograms to predict survival after colorectal cancer resection without preoperative therapy. BMC Cancer 2016;16:658.
Mounce LTA, Price S, Valderas JM, . Comorbid conditions delay diagnosis of colorectal cancer: a cohort study using electronic primary care records. Br J Cancer 2017;116:1536–1543.
Stuart BC, Davidoff AJ, Erten MZ. Changes in medication management after a diagnosis of cancer among Medicare beneficiaries with diabetes. J Oncol Pract 2015;11:429–434.